Approvals and Withdrawals: Inside the Cancer Drug Terrain of 2022
Last year, the FDA approved almost a dozen novel cancer drugs and expanded indications for many more, while growing agency scrutiny led to numerous withdrawals.
Source: medscape.com
Stay updated with breaking news from Ginna Laport. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Last year, the FDA approved almost a dozen novel cancer drugs and expanded indications for many more, while growing agency scrutiny led to numerous withdrawals.